Investor Kit

Company Profile

Founded in 1995, Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders.

Acorda has an industry leading pipeline of novel neurological therapies addressing a range of disorders, including Parkinson's disease, migraine and multiple sclerosis. Acorda markets two FDA-approved therapies, including INBRIJA™ (levodopa inhalation powder).

Stock Chart

Financials

Date Filing Description Download
08/10/20 DEFA14A Additional Proxy Soliciting Materials (definitive)
08/10/20 SC 13G/A Amended Statement of Ownership
08/10/20 10-Q Quarterly Report
08/04/20 DEFA14A Additional Proxy Soliciting Materials (definitive)

Email Alerts

Un-subscribe from email alerts
Email Address *
Mailing Lists *





 
Enter the code shown above.